Literature DB >> 22138546

Metabolism of 17-alpha-hydroxyprogesterone caproate by human placental mitochondria.

Valentina M Fokina1, Olga L Zharikova, Gary D V Hankins, Mahmoud S Ahmed, Tatiana N Nanovskaya.   

Abstract

Perfusion of 17-alpha-hydroxyprogesterone caproate (17HPC) via the maternal circuit of a dually perfused human placental lobule resulted in the extensive formation of 2 metabolites. On the other hand, human placental microsomes biotransformed 17HPC into 5 monohydroxylated metabolites, which did not correspond to those formed during perfusion. The goal of this investigation was to determine the subcellular localization of the enzymes responsible for the biotransformation of 17HPC during its perfusion in human placenta. Crude subcellular fractions of the human placental tissue were utilized. Six 17HPC metabolites were formed by the placental mitochondrial fraction, of which 4 were identical to those formed by the microsomes; whereas the other 2, namely MM and M₁₉, were formed by the mitochondrial fraction only. The latter metabolites were identical to those formed during 17HPC perfusion, as determined by liquid chromatography-mass spectrometry (LC-MS) analysis. Therefore, these data strongly suggest that the enzymes responsible for the biotransformation of 17HPC during its perfusion are predominantly localized in human placental mitochondria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138546      PMCID: PMC3864459          DOI: 10.1177/1933719111419248

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  10 in total

1.  Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).

Authors:  Bernd Clement; Sabine Mau; Stephanie Deters; Antje Havemeyer
Journal:  Drug Metab Dispos       Date:  2005-08-23       Impact factor: 3.922

2.  Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.

Authors:  Eduardo B da Fonseca; Roberto E Bittar; Mario H B Carvalho; Marcelo Zugaib
Journal:  Am J Obstet Gynecol       Date:  2003-02       Impact factor: 8.661

3.  Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate.

Authors:  Sarah J Hemauer; Ru Yan; Svetlana L Patrikeeva; Donald R Mattison; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Am J Obstet Gynecol       Date:  2008-08       Impact factor: 8.661

4.  Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions.

Authors:  Nicole K Ruddock; Shao-Qing Shi; Sangeeta Jain; Gradie Moore; Gary D V Hankins; Roberto Romero; Robert E Garfield
Journal:  Am J Obstet Gynecol       Date:  2008-10       Impact factor: 8.661

5.  Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma. Pharmacokinetics and effects on adrenal function.

Authors:  M Onsrud; E Paus; E Haug; K Kjørstad
Journal:  Acta Obstet Gynecol Scand       Date:  1985       Impact factor: 3.636

6.  Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons.

Authors:  Ru Yan; Tatiana N Nanovskaya; Olga L Zharikova; Donald R Mattison; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biochem Pharmacol       Date:  2008-02-07       Impact factor: 5.858

7.  The effect of esterases on 17alpha-hydroxyprogesterone caproate.

Authors:  Ru Yan; Valentina Fokina; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Am J Obstet Gynecol       Date:  2007-10-22       Impact factor: 8.661

8.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

9.  Aromatase is the major enzyme metabolizing buprenorphine in human placenta.

Authors:  Sujal V Deshmukh; Tatiana N Nanovskaya; Mahmoud S Ahmed
Journal:  J Pharmacol Exp Ther       Date:  2003-06-13       Impact factor: 4.030

10.  Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro.

Authors:  Donal J Sexton; Michael W O'Reilly; Anne M Friel; John J Morrison
Journal:  Reprod Biol Endocrinol       Date:  2004-12-07       Impact factor: 5.211

  10 in total
  5 in total

Review 1.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

2.  In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring.

Authors:  Caitlin C Murphy; Piera M Cirillo; Nickilou Y Krigbaum; Barbara A Cohn
Journal:  Am J Obstet Gynecol       Date:  2021-11-09       Impact factor: 10.693

3.  Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation.

Authors:  Juilee Rege; Yasuhiro Nakamura; Fumitoshi Satoh; Ryo Morimoto; Michael R Kennedy; Lawrence C Layman; Seijiro Honma; Hironobu Sasano; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

4.  Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.

Authors:  Steve N Caritis; Shringi Sharma; Raman Venkataramanan; Gary D Hankins; Menachem Miodovnik; Mary F Hebert; Jason G Umans; Thomas Benedetti; Donald Mattison; Anne Zajicek; Dawn Fischer; Aimee Jackson
Journal:  Am J Obstet Gynecol       Date:  2012-08-16       Impact factor: 8.661

Review 5.  Basic obstetric pharmacology.

Authors:  Yang Zhao; Mary F Hebert; Raman Venkataramanan
Journal:  Semin Perinatol       Date:  2014-10-01       Impact factor: 3.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.